Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cel-Sci Corp
(NY:
CVM
)
0.5992
-0.0053 (-0.88%)
Streaming Delayed Price
Updated: 10:07 AM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cel-Sci Corp
< Previous
1
2
3
4
5
6
Next >
Why Pinterest Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket
October 28, 2022
Gainers Zovio Inc (NASDAQ: ZVO) rose 39.5% to $0.2449 in pre-market trading after gaining 7% on Thursday.
Via
Benzinga
CEL-SCI’S Multikine Reduced 5-year Death Rate From 54% to 22% in Phase 3 Study Patients Who Were Early Tumor Responders Prior to Any Standard of Care Treatment
October 17, 2022
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI’S Phase 3 Data Presented at ESMO 2022: Neoadjuvant Multikine Achieved Groundbreaking Tumor Response & Extended Overall Survival in Locally Advanced Head and Neck Cancer
September 12, 2022
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Corporation Issues Letter to Shareholders
September 07, 2022
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Corporation Announces Phase 3 Multikine® Head and Neck Cancer Results Posted on Clinicaltrials.gov
August 19, 2022
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Corporation Reports Third Quarter Fiscal 2022 Financial Results
August 15, 2022
From
CEL-SCI Corporation
Via
Business Wire
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
August 16, 2022
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.
Via
Benzinga
CEL-SCI Appoints Dr. Gail Naughton to Its Board of Directors
August 08, 2022
From
CEL-SCI Corporation
Via
Business Wire
Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
July 18, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering...
Via
Benzinga
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
July 15, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
Via
Benzinga
CEL-SCI Corporation Announces Reddit AMA with Geert Kersten
July 14, 2022
From
CEL-SCI Corporation
Via
Business Wire
TinyGemsBreaks – SRAX Inc. (NASDAQ: SRAX) Shares Replays of 2022 LD Micro Invitational Company Presentations
June 16, 2022
Via
Investor Brand Network
CEL-SCI Corporation to Present at LD Micro Invitational
June 08, 2022
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Presents Phase 3 Multikine Head & Neck Cancer Data at ASCO
June 07, 2022
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Announces Publication of ASCO 2022 Abstracts
May 27, 2022
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Corporation Reports Second Quarter Fiscal 2022 Financial Results
May 16, 2022
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Announces Acceptance of Abstracts to ASCO 2022
April 22, 2022
From
CEL-SCI Corporation
Via
Business Wire
28 Stocks Moving In Wednesday's Mid-Day Session
April 20, 2022
Gainers Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) climbed 58.3% to $2.2950 after jumping around 22% on Tuesday. AlloVir, Inc. (NASDAQ: ALVR) shares climbed 39% to $7.52...
Via
Benzinga
53 Biggest Movers From Yesterday
April 21, 2022
Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum...
Via
Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
April 19, 2022
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $...
Via
Benzinga
54 Biggest Movers From Yesterday
April 20, 2022
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...
Via
Benzinga
34 Stocks Moving In Monday's Mid-Day Session
April 18, 2022
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions....
Via
Benzinga
68 Biggest Movers From Yesterday
April 19, 2022
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...
Via
Benzinga
CEL-SCI Corporation Reports First Quarter Fiscal 2022 Financial Results
February 14, 2022
From
CEL-SCI Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022
April 07, 2022
Upgrades
Via
Benzinga
Here's How Much $100 Invested In CEL-SCI 5 Years Ago Would Be Worth Today
January 04, 2022
CEL-SCI (AMEX:CVM) has outperformed the market over the past 5 years by 5.04% on an annualized basis. Buying $100 In CVM: 5 years ago, an investor could have purchased 35.56...
Via
Benzinga
CEL-SCI Reports Fiscal 2021 Financial Results and Clinical & Corporate Developments
December 22, 2021
From
CEL-SCI Corporation
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 16, 2021
Good morning, trader! We're getting right into the swing of things with a breakdown of the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
CEL-SCI Corporation Completes Commercial-Scale Buildout of Multikine Manufacturing Facility
October 22, 2021
From
CEL-SCI Corporation
Via
Business Wire
Jim Cramer Prefers This Stock Over Mogo, Considers Endeavor Group As Inexpensive
October 19, 2021
On CNBC’s "Mad Money Lightning Ro...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.